Incretins are substances that promote insulin release to lower blood sugars
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
The FDA approved a higher dose (2.4 mg) of Semaglutide, specifically for chronic weight management in adults with obesity or overweight individuals with at least one weight-related condition
It is not intended for human consumption, medical use, diagnostic use, therapeutic use, weight-loss use, appetite-control use, glucose-management use, diabetes treatment use, obesity treatment use, supplement use, injection use, or the treatment, prevention, or diagnosis of any disease
Herein, to investigate the production of ROS, HUVECs were subjected to high glucose medium (HG, 45 mM Dglucose)